It's a rare condition in which even minimal amounts of UV radiation are deadly to the skin. Left untreated, a child will likely die before age 10. Sadly, xeroderma pigmentosum has devastated the local population of a small Guatemalan town. Dr. Bari Cunningham, associate professor of pediatric dermatology at the University of California, San Diego School of Medicine, talks with host Dr. Andrew Krakowski about a journey through the wilderness of Guatemala, where the autosomal recessive disease has cast a shadow on life in this village. But a new day may be dawning for these people, thanks to a support team that is now championing their cause.
Xeroderma Pigmentosum in the Crosshairs: A Dermatologist's Journey to Guatemala, Part 1

Transcript
Xeroderma Pigmentosum in the Crosshairs: A Dermatologist's Journey to Guatemala, Part 1
closeReady to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
It's a rare condition in which even minimal amounts of UV radiation are deadly to the skin. Left untreated, a child will likely die before age 10. Sadly, xeroderma pigmentosum has devastated the local population of a small Guatemalan town. Dr. Bari Cunningham, associate professor of pediatric dermatology at the University of California, San Diego School of Medicine, talks with host Dr. Andrew Krakowski about a journey through the wilderness of Guatemala, where the autosomal recessive disease has cast a shadow on life in this village. But a new day may be dawning for these people, thanks to a support team that is now championing their cause.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Love Story: Lipid Education for Women’s Heart Health
Biomarkers of the Storm: Decoding IRI’s Signature
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?